Standard Operating Procedure for Harmonizing MCB/WCB Data with QA System in Biosimilar Development
Department | Biosimilars |
---|---|
SOP No. | SOP/BS/052/2025 |
Supersedes | SOP/BS/052/2022 |
Page No. | Page 1 of 10 |
Issue Date | 04/05/2025 |
Effective Date | 06/05/2025 |
Review Date | 04/05/2026 |
1. Purpose
To define the procedure for harmonizing Master Cell Bank (MCB) and Working Cell Bank (WCB) data with Quality Assurance (QA) systems in biosimilar development, ensuring consistent documentation, traceability, and GMP compliance.
2. Scope
This SOP applies to all data related to the creation, characterization, testing, and archival of MCB and WCB records, and the processes for integration with QA-managed documentation systems.
3. Responsibilities
- CLD Team: Generates, maintains, and updates MCB/WCB documentation in alignment with lab records.
- QA Department: Verifies completeness and accuracy of MCB/WCB data; integrates into official QA-controlled systems.
- Head of Biosimilars: Ensures procedural adherence and final approval of harmonized records.
4. Accountability
The Head of QA is accountable for ensuring that all MCB and WCB records are harmonized, traceable, and ready for internal or external audits as per regulatory standards.
5. Procedure
5.1 Creation of MCB/WCB Documentation Set
- Ensure the following documents are compiled post-banking:
- Cell Bank Production Report
- Analytical Test Results (e.g., sterility, mycoplasma, identity)
- Cryopreservation Protocol
- Storage Location Map
5.2 Internal Record Verification
- Cross-verify:
- Banking date and passage number
- Freezer ID and vial labeling
- Test results and equipment calibration logs
- Document verification outcomes in the Record Reconciliation Sheet (Annexure-1).
5.3 QA Review and Integration
- Submit verified records to QA for master file integration.
- QA to assign QA Document ID and enter into QA Register (Annexure-2).
- Files to be indexed with electronic and physical folder names clearly labeled.
5.4 Discrepancy Resolution
- Any mismatch between lab data and QA entries must trigger a controlled deviation.
- Deviation must be closed prior to final approval by QA.
5.5 Archival and Audit Readiness
- Store harmonized documentation in QA-controlled archives.
- Backup electronic files on secure QA server with restricted access.
- Review completeness during annual GMP internal audit.
6. Abbreviations
- MCB: Master Cell Bank
- WCB: Working Cell Bank
- CLD: Cell Line Development
- QA: Quality Assurance
- GMP: Good Manufacturing Practice
7. Documents
- Record Reconciliation Sheet (Annexure-1)
- QA Cell Bank Integration Register (Annexure-2)
8. References
- ICH Q5D – Derivation and Characterization of Cell Substrates
- WHO Technical Report Series 978 – Annex 3
- 21 CFR Part 211 – Subpart J: Records and Reports
9. SOP Version
Version: 2.0
10. Approval Section
Prepared By | Checked By | Approved By | |
---|---|---|---|
Signature | |||
Date | |||
Name | |||
Designation | |||
Department |
11. Annexures
Annexure-1: Record Reconciliation Sheet
Record Type | CLD Entry | QA Entry | Verified By | Date |
---|---|---|---|---|
Banking Date | 28/04/2025 | 28/04/2025 | Ajay Verma | 01/05/2025 |
Annexure-2: QA Cell Bank Integration Register
QA Doc ID | Cell Bank ID | CLD File Ref | Entry Date | Integrated By |
---|---|---|---|---|
QA-MCB-042 | MCB-CHO-017 | CLD-MCB-017 | 01/05/2025 | Sunita Reddy |
Revision History:
Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
---|---|---|---|---|
04/05/2025 | 2.0 | Integrated QA documentation workflow and reconciliation protocol | Process Standardization |